Dr Esther Camp-Dotlic
Research Development Manager
Research Services
Research & Innovation
Esther has a research background in progenitor cell biology, migration and differentiation during development and tissue remodelling in vertebrates. She joined the Mesenchymal Stem Cell Research Group in 2013 after having worked as a post-doctoral scientist in Australia, Spain and the UK. Her work focused on understanding the molecular mechanisms that control mesenchymal stem/progenitor cell (MSC) proliferation and differentiation during cranial development. The projects she developed included; investigating the role of the transcription factor Twist-1 and microRNAs in skeletal bone derived MSC and cranial cells. She also led a number of pre-clinical trials investigating the efficiency and safety of drugs to prevent abnormal cranial suture fusion.
In 2022 she took up the position of Senior Research Development Specialist within Research Services. In this role she specialises in all areas of grant development support and management for Category 1 grants and fellowships offered by National Health and Medical Research Council (NHMRC), Medical Research Future Fund (MRFF), Snow Medical and Australian Cancer Research Foundation. She contributes to the planning and delivery of educational workshops and drop-in sessions outlining the important elements to consider when applying for grant and fellowship opportunities. She also provides one on one strategic advice on specific grant opportunities, preparing resources to assist researchers with writing their application, providing high-quality proposal development and review.
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Spanish; Castilian | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| The University of Adelaide | Australia | PhD |
| Year | Citation |
|---|---|
| 2018 | Camp, E., Anderson, P., Zannettino, A., & Gronthos, S. (2018). Inhibition of tyrosine kinase receptor C-ROS-1 as a novel treatment for patients with TWIST haploinsufficiency induced craniosynostosis. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 33 (pp. 424). Montreal, CANADA: WILEY. |
| 2005 | Camp-Dotlic, E., Froiland, D., Kind, K., Irving-Rodgers, H., Thompson, J., & Russell, D. (2005). Murine HIF-1a localisation by immunohistochemistry in a mouse reproductive tissue. In Reproduction Fertility and Development Vol. 17 (pp. 129). C S I R O Publishing. DOI |
Medical Research Future Fund: 2020 Stem Cell Therapies Grant opportunity-A Precision Medicine Based Approach to Treat Craniosynostosis in Children (2021-2023)
National Health and Medical Research Council- Histone Demethylase KDM6 is a novel target for treating craniosynostosis in children with Saethre-Chotzen Syndrome(2018-2020).
National Health and Medical Research Council- Tyrosine Kinase receptor c-ros-oncogene 1 mediates TWIST-1 haploinsufficiency induced craniosynostosis in children: A novel therapeutic target (2017-2019).
Channel 7 Children's Research Foundation of SA Inc, Identification of TWIST-1 regulated microRNAs which control cranial bone development in children (2015).
British Society of Developmental Biology Travel Grant (2011).
John and Pamela Salter Charitable Trust Grant UK (2010).
MYORES Exchange Fund grant. MYORES: European Muscle Development Network (2009).
Cellular and Systems Neurobiology
Physiology 2A, 2B
Principles of Human Health and Disease
Biology of Disease
Dental Science and Practice 1 Part 1
Human Biology IOH Part 2
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2018 - 2022 | Co-Supervisor | The Role of Epigenetic Modifiers, Kdm6a and Kdm6b, in Calvarial Suture Development and Craniosynostosis | Doctor of Philosophy | Doctorate | Full Time | Miss Clara Pribadi |
| 2016 - 2019 | Co-Supervisor | Identification of Molecular Mechanisms Mediating TWIST-1 Regulation of Mesenchymal Stem Cell Proliferation and Differentiation | Doctor of Philosophy | Doctorate | Full Time | Mr Chee Ho H'ng |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2017 - 2017 | Co-Supervisor | Targeting Tyrosinase Kinase Receptor C-ROS-Oncogene 1 to reduce aberrant osteogenesis in Twist-1 haploinsufficiency induced craniosynostosis | The University of Adelaide | - | Honours | Full Time | Gabrielle Fusco-Allison |